-
1 Comment
Bringspring Science and Technology Co., Ltd is currently in a long term downtrend where the price is trading 18.2% below its 200 day moving average.
From a valuation standpoint, the stock is 36.5% cheaper than other stocks from the Technology sector with a price to sales ratio of 5.1.
Bringspring Science and Technology Co., Ltd's total revenue rose by 20.3% to $200M since the same quarter in the previous year.
Its net income has increased by 224.2% to $8M since the same quarter in the previous year.
Finally, its free cash flow grew by 199.3% to $24M since the same quarter in the previous year.
Based on the above factors, Bringspring Science and Technology Co., Ltd gets an overall score of 4/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100001C30 |
| Sector | Technology |
| Industry | Information Technology Services |
| Beta | -0.07 |
|---|---|
| Target Price | None |
| PE Ratio | None |
| Market Cap | 15B |
| Dividend Yield | None |
Bringspring Science and Technology Co., Ltd. primarily engages in the smart healthcare business in China. It operates through Health Care and Social Security, Government and Public Utilities, and Others segments. The company's smart medical records services include medical record statistics management, integrated medical records, medical record tracing, digital medical records, paperless medical record management, micro medical records, and self-service printing terminals. Its DRG/DIP services also comprise DRG medical insurance operation supervision systems, DRG medical service operation supervision systems, medical insurance settlement list reporting, and DIP medical insurance operation supervision systems; and medical quality control services include medical record homepage quality control system, medical insurance intelligent review system, medical insurance settlement list management system, and full-process medical record quality control system. In addition, the company's medical management services comprise hospital grade review, single disease management system, medical safety (adverse) event management system, and digital follow-up system; and data analysis and reporting services include performance appraisal homepage report, HQMS, respiratory diseases, NCIS medical services and quality safety, national drugs and consumables, and anti-tumor drugs, as well as medical platform services comprise provincial and municipal comprehensive supervision platform, public hospital performance assessment, and medical insurance payment platform. Further, it offers smart city solutions and artificial intelligence applications. The company was founded in 2005 and is headquartered in Shenyang, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300290.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
